36666511000001100: Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\UK product\Virtual medicinal product\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\UK product\Virtual therapeutic moiety\Gemcitabine\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\UK product\Virtual therapeutic moiety\Gemcitabine\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Product containing gemcitabine in parenteral dose form (medicinal product form)\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Product containing gemcitabine in parenteral dose form (medicinal product form)\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Gemcitabine\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing gemcitabine\Product containing gemcitabine in parenteral dose form (medicinal product form)\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)
\Medicinal product\Product manufactured as parenteral dose form\Product containing gemcitabine in parenteral dose form (medicinal product form)\Product containing only gemcitabine in parenteral dose form (medicinal product form)\Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection\Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Mar 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

561041000001114 Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

561051000001112 Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Is a	Product containing precisely gemcitabine (as gemcitabine hydrochloride) 200 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has manufactured dose form	Powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has basis of strength substance	Gemcitabine	true	Inferred relationship	Existential restriction modifier	1
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has presentation strength numerator value	200	false	Inferred relationship	Existential restriction modifier	1
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has presentation strength denominator unit	Vial	true	Inferred relationship	Existential restriction modifier	1
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has precise active ingredient	Gemcitabine hydrochloride	true	Inferred relationship	Existential restriction modifier	1
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has unit of presentation	Vial	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has specific active ingredient	Gemcitabine hydrochloride	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Gemcitabine	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) 1 vial	Has AMP	True	Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
561041000001114	Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
561051000001112	Gemcitabine 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module